Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Hexetidine

    • Product Name Hexetidine
    • Alias Bactidol
    • Einecs 203-872-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    266736

    Generic Name Hexetidine
    Chemical Formula C21H45N3
    Molecular Weight 339.6 g/mol
    Appearance Clear, colorless to pale yellow liquid
    Solubility Slightly soluble in water, soluble in alcohol
    Pharmacological Class Antiseptic
    Main Use Mouthwash for oral infections
    Mechanism Of Action Disrupts microbial cell walls
    Route Of Administration Topical (oral rinse, throat spray)
    Shelf Life Approximately 2-3 years unopened
    Storage Temperature Store below 30°C
    Odor Mild characteristic odor

    As an accredited Hexetidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Hexetidine is packaged in a 500 mL amber glass bottle with a secure screw cap, featuring a hazard label and product details.
    Shipping Hexetidine should be shipped in well-sealed, labeled containers that protect it from light and moisture. Transport in accordance with local, national, and international regulations for chemical substances. Ensure upright positioning to prevent leaks and provide safety data sheets (SDS) alongside the shipment for proper handling and emergency procedures.
    Storage Hexetidine should be stored in a tightly closed container, away from direct sunlight, heat, and moisture. Keep it at room temperature, ideally between 15°C and 30°C (59°F–86°F). Store in a well-ventilated, cool, and dry area away from incompatible substances such as strong oxidizers. Ensure that the storage area is secure and inaccessible to unauthorized personnel, especially children.
    Application of Hexetidine

    Applications of Hexetidine in Industrial Manufacturing

    Hexetidine serves as a specialty antimicrobial and antiseptic ingredient in several regulated industries, where manufacturers rely on its broad-spectrum activity and compatibility with various finished product formats. We supply Hexetidine globally to stringent quality and compliance requirements, supporting forward integration across unique industrial segments from oral healthcare to veterinary products. Below, we detail prominent downstream use cases with exact formulation standards, usage parameters, and process integration for industry partners.

    1. Oral Healthcare Rinse and Mouthwash Manufacturing

    Many prominent oral rinse and mouthwash producers specify Hexetidine due to its established track record in controlling oral pathogen populations, meeting industry and pharmacopoeial standards for antiseptic rinses. In commercial production, formulation chemists incorporate Hexetidine at carefully controlled ratios, balancing user safety with antimicrobial performance, and integrating it post-dilution during blending and homogenization stages to ensure consistent dispersion. Oral healthcare companies package the compounded liquid into retail glass or HDPE bottles for over-the-counter sale, often targeting the treatment and prevention of gingivitis, mouth ulcers, and post-dental surgical care.

    Industry compliance standards

    • European Pharmacopoeia (Ph. Eur.): Monograph 07/2012:1039
    • United States Pharmacopeia (USP) <1072>, Antiseptic Products
    • ISO 9001 certified manufacturing under GMP
    • Local FDA or NMPA (China) registration for oral antiseptics

    Typical usage ratio

    • 0.1% to 0.2% w/v in finished mouthwash, adjusted per regulatory and microbial load requirements

    Downstream process integration

    • Blended into aqueous vehicle after filtration but prior to bottling, often alongside flavorants, sweeteners, and color additives

    Final product types

    • Medicated mouthwashes (e.g., gingivitis rinse)
    • Pre-surgical oral irrigation solutions
    • Post-procedural oral wound care rinses

    2. Pharmaceutical Throat Spray and Lozenge Production

    Hexetidine forms a core antimicrobial agent in throat sprays and lozenges made for symptomatic relief in pharyngitis and topical throat infections, following pharmacopoeial monographs and regional medicine control standards. Production lines dissolve or disperse Hexetidine into a solubilizing excipient base, typically at controlled cooling, to maintain chemical stability prior to spray bottle filling or lozenge compression. Multinational and regional pharmaceutical manufacturers focus on tablet uniformity or consistent spray actuation, leading to strict control over the mixing and filling steps.

    Industry compliance standards

    • British Pharmacopoeia (BP) requirements for antimicrobial actives in oropharyngeal preparations
    • ICH Q7: GMP for Active Pharmaceutical Ingredients
    • GDP guidelines for pharmaceutical finished goods
    • Medicines and Healthcare products Regulatory Agency (MHRA) or EMA product registration

    Typical usage ratio

    • 0.1% in aqueous throat sprays; up to 0.2% in solid lozenges, subject to regional therapeutic maximums

    Downstream process integration

    • Dissolved in excipient solution prior to final blending and filling (sprays) or dry-blended with bulk lozenge ingredients before tableting

    Final product types

    • OTC throat sprays
    • Medicated lozenges for sore throat relief
    • Prescription-strength oropharyngeal spray formulations

    3. Topical Veterinary Antiseptic Formulation

    Veterinary health product manufacturers use Hexetidine for livestock and companion animal antiseptics intended to treat and prevent skin and mucosal infections. Following veterinary pharmacopeial regulations (including those in the EU and APAC), formulators incorporate Hexetidine into aqueous or semi-solid bases during emulsification or solution preparation, ensuring even distribution without loss of antimicrobial activity. These actives are critical in wound sprays, topical cleansers, and post-operative animal care formulations where operator safety and animal tolerance are closely monitored.

    Industry compliance standards

    • Veterinary Medicines Regulations (EU, VMD-UK)
    • OIE terrestrial manual guidelines (chapter for antiseptic agents)
    • Good Manufacturing Practice for Veterinary Medicinal Products (EU GMP Volume 4)
    • VICH GL42 guideline for veterinary pharmaceutical development

    Typical usage ratio

    • 0.15% to 0.3% by weight in skin spray and wound care solutions, subject to animal tolerance trials

    Downstream process integration

    • Introduced during aqueous phase blending or cream base milling; pre-diluted to avoid hot-spotting, with batch QC testing for titer and homogeneity

    Final product types

    • Veterinary wound cleansing sprays
    • Antiseptic topical gels and solutions for livestock
    • Post-surgical antiseptic rinses for companion animals

    4. Preoperative Antiseptic Solution Manufacturing

    Medical device and hospital supply manufacturers employ Hexetidine as a preoperative skin cleanser and mucosal antiseptic, preparing single-use or multi-dose solutions in compliance with official hospital aseptic protocols and regional medical device standards. The compound is solubilized in sterile water adjusted for osmolarity and pH, introduced at the mixing tank prior to sterile filtration, and packaged in sealed medical-grade containers. Warehouses track batches under full cold chain and chain-of-custody documentation, guaranteeing integrity up to the point-of-care. Clinical procurement may specify label concentrations according to both regulatory limits and the intended application area.

    Industry compliance standards

    • ISO 13485:2016 Quality Management for Medical Devices
    • EN 13727: Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of bactericidal activity
    • FDA CFR Title 21 Part 880 for healthcare antiseptics
    • Hospital Infection Society protocols for preoperative preparations

    Typical usage ratio

    • 0.1% to 0.2% in finished antiseptic solutions, adjusted for application site (skin, mucosa) and local regulation

    Downstream process integration

    • Dissolved directly into sterile water tanks post preliminary filtration, followed by terminal sterilization or aseptic filtration prior to bottling or pouch filling

    Final product types

    • Preoperative skin and mucosal antiseptic solutions
    • Single-use surgical prep packs
    • Hospital pharmacy antiseptic compounding bases

    5. Medical Oral Spray and Gel Production

    Hospitals and outpatient clinics require specialized oral antiseptic sprays and gels containing Hexetidine for targeted mucosal infection control, post-surgical care, and stomatitis management. Pharmaceutical manufacturers formulate these gels or sprays by solubilizing Hexetidine in glycerol-water blends or gel-forming polymers, maintaining pH and viscosity for safe mucosal adhesion. Blending occurs under validated GMP protocols to ensure microbial control in the finished unit dose or metered spray packaging, following strict QA release prior to hospital distribution.

    Industry compliance standards

    • GMP for finished pharmaceuticals (WHO, EU-GMP and relevant regional codes)
    • EN ISO 14644 cleanroom control for sterile oral care products
    • Pharmacopeial acceptance criteria for topical oral formulations
    • National registration with health authorities (e.g., ANVISA, SFDA)

    Typical usage ratio

    • 0.1% to 0.15%, titrated according to mucosal contact time and age group safety profiles

    Downstream process integration

    • Added post-pasteurization into cooled intermediate, either before gelling (for sprays) or immediately following hydrocolloid addition (for gels)

    Final product types

    • Oral mucosal antiseptic sprays for clinics and dental offices
    • Prescription gel for oral lesions, stomatitis, or post-extraction wound care
    • Multi-use oral infection control sachets
    Free Quote

    Competitive Hexetidine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Hexetidine: Hands-On Experience From The Manufacturing Floor

    Bringing Clarity to What Sets Our Hexetidine Apart

    Manufacturing chemicals is a practical business. Every batch depends on raw material consistency, process precision, and decades of hands-on knowledge. When customers ask about Hexetidine, I always picture our full tanks, the hum of chillers running overnight, and the smell that drifts through the air as the reaction reaches completion. We measure our craft by reliability, and in this business, you remember all the wrinkles that come up along the way.

    Not every antimicrobial agent works the same on a real-world production line. Hexetidine, a broad-spectrum antiseptic, draws attention in the personal care and healthcare industries because of its balance—the molecule disrupts microbial growth but maintains stability in varied formulations. After years at the plant, I see where purity leaves its mark. Our production lines never get away with shortcuts: any drop in quality in the Hexetidine synthesis shows right away, whether that’s cloudiness in a mouthwash, unwanted odor, or a subtle shift in pH. Each stage—oximation, neutralization, crystalline isolation—pushes us to examine details. A bit too much heat during isolation, and you risk impurities that no filtration can fix. Time, testing, and carefully maintaining temperature windows have taught us how not to waste raw material, yet never compromise purity.

    We usually produce Hexetidine under the model code HEX-M98, signaling a purity verified above 98%. Consistency at this grade isn’t an accident. Every shipment starts with carefully sourced 1,3-diisopropyl-5-aminopentane as our key raw material, scrutinized for trace amines that upset final characteristics. The learning curve, especially for scaling up from pilot to full-batch, taught us the necessity of precise solvent control; too much residual organic carries through the process, and small trace levels alter the smell and color even if chemical purity reads fine. Clients judge these differences in the field, far beyond a line on a spec sheet.

    Core Specifications That Matter in Daily Work

    On the ground, reliable batch reproducibility matters just as much as analytical specs. Our Hexetidine never strays from its range: white crystalline powder, melting point just above 120°C, free of discernible aldehyde odor. Water solubility at room temperature gives the product a big edge for formulating oral care products, especially mouthwashes and gargles that need smooth dissolution without creating micrograins or residue.

    Traditionally, competitors have struggled with off-white color or faint contamination by precursor amines, leading to yellowed solutions. Our crew adjusted reaction times and phase separation steps on the line, dropped extended solvent washes, and integrated continuous testing during crystallization. The difference shows up not just in the test lab, but when customers pour Hexetidine-based syrup or rinse it for color and clarity—details that come up in batch recall meetings months down the road if not handled at the source.

    Hexetidine’s antimicrobial spectrum covers gram-positive and gram-negative bacteria, with a proven record against oral pathogens. As a producer, we back up claims with real batch data: every lot faces microbial challenge panels running standard strains like Staphylococcus aureus, Streptococcus pyogenes, and Candida albicans. A decade of records has shown there’s no skimping on monitoring residuals and knowing exactly which contaminants sneak past. Instead of relying on broad assertions, we show detailed microbial panel results with each certificate of analysis.

    End Uses and Feedback From Real-World Customers

    After years supplying Hexetidine, we’ve heard from manufacturers of mouthwash, medicated creams, wound care gels, and veterinary antiseptics. Nothing has shaped our process more than their shared feedback. In oral care, for example, blunting of taste or aftertaste quickly leads to reformulation requests, so a cleaner product means fewer product recalls or customer complaints. Pharmacies need a Hexetidine that dissolves smoothly, since granulation or filminess ruins the transparent look and feel of rinse products.

    Wound care producers value stable pH and minimal reactivity with other actives. One client noted that even small changes in solvent residue altered shelf life and brought packaging compatibility questions. We responded by switching to two-stage vacuum drying, ending up with Hexetidine that avoids yellowing or secondary reactions, reducing the frequency of field returns. These kinds of insights don’t show on spec sheets, but they influence day-to-day choices on the manufacturing floor—how long to run a final wash, the right temperature curve, or acceptable drying time.

    Veterinary users point out viscosity challenges in formulating topical ointments. Our observations match their experience: highly pure, low-residual Hexetidine blends better with fatty bases, giving uniform texture that doesn’t separate inside tubes. We send pilot-scale samples and collect results, refining our method batch by batch.

    Where Hexetidine Differs From Similar Agents

    Over years in this sector, we’ve handled a basket of biocidal actives: chlorhexidine, povidone-iodine, cetylpyridinium chloride, and benzalkonium chloride. Each finds a niche, usually determined by their risk profile, solubility, and impact on formulation. Chlorhexidine often triggers taste disturbances and stains teeth, so product developers look elsewhere for mouthwashes where Hexetidine instead delivers broad-spectrum kill without coloring teeth or severely altering oral microbiota.

    Povidone-iodine, though effective as a hospital-grade disinfectant, leaves color and strong odor—two things nearly impossible to mask in personal care. Hexetidine comes out ahead in all situations where clarity, low odor, and compatibility with flavorings matter, such as consumer mouth rinses. Compared to quaternary ammoniums like benzalkonium chloride, Hexetidine remains less irritating to mucous membranes, especially in sensitive formulations for children or those with predisposed tissue reactivity.

    We keep an eye on global regulations. Hexetidine remains in approved lists across the European Union, Asia-Pacific countries, and parts of the Americas, while other actives come and go due to shifting toxicological profiles. This regulatory stability has meant our customers don’t need to pivot to alternate actives every product cycle, which reduces long-term reformulation headaches. Instead of recurring compliance updates, buyers can count on consistent approval status with Hexetidine and focus on improving their own formulations.

    Risks We See, and How We Handle Them

    Making Hexetidine isn’t just a matter of mixing and packaging. Safety underpins every batch, with close attention paid to emissions, waste water, and operator exposure. Our crews follow best practices since minor lapses are costly, not just in regulatory terms but in safety of everyone at the plant. Hexetidine’s manageable volatility and low vapor pressure do reduce airborne contamination risk compared to more volatile or reactive biocides—an advantage we drive home during annual training.

    We remember a decade back, when a batch of low-purity Hexetidine reached a customer in South Asia. That shipment set off a full review of raw material traceability—every barrel tracked, every solvent catalogued. Since then, we’ve built out a tightly controlled supply chain, complete with advance analytic reports and full retention samples for every batch. If an anomaly pops up—say, a drop in color index or trace contamination with unknown organics—troubleshooting doesn’t begin with speculation; it starts with batch logs, archived samples, and process simulations.

    Disposal of Hexetidine-containing liquid and off-spec solid waste stands out as another head-on challenge. Our site engineers commissioned specialized effluent treatment, addressing local watershed contamination concerns raised by municipal authorities. We know fielding questions from regulatory agencies beats legal hassles or environmental risk that could shut down the plant. By auditing every stage, from receiving to finished good, we avoid surprises.

    Supporting Data and the Importance of Real Testing

    Claims alone don’t satisfy seasoned buyers. Our Hexetidine lots leave the facility only after rigorous verification, combining gas chromatography assay, water content analysis by Karl Fischer titration, loss on drying, and full spectrophotometric scan. Even with digital records, old-school batch logs remain a backbone. Over the years, clients have asked for original raw data from testing Pipette volumes, exact reaction batch times, and real temperature logs. Big clients, particularly multinationals, frequently conduct plant audits. They walk the line, open storage tanks, inspect batch labeling, and review logs right at the shop floor, not relying on marketing talk or sales team assurances.

    The data tell the story. In the last five years, our Hexetidine batches have maintained a standard deviation in purity under 0.25%, and complaints about odor or solubility dropped by more than half after we switched to an improved crystallization protocol. In performance comparisons, Hexetidine continues to match or exceed bactericidal and fungicidal benchmarks set for oral care, even when tested in complex matrices with real salivary enzymes or under ‘dirty’ conditions simulating wound fluid.

    Production Scale, Capacity Challenges, and Resource Choices

    Hexetidine isn’t made in a vacuum—sudden surges in demand during flu season or in response to disease outbreaks stretch plant capacity. To keep output steady, we plan downtime in advance, rotate shifts, and keep a dedicated maintenance engineer on the line during busy spells. Those choices mean more than efficiency—they prevent bottlenecks that tempt risky process shortcuts.

    Raw material sourcing always presents its headaches. Supply chain interruptions—especially for precursor amines—can derail timelines. We overcame these hurdles by qualifying backup suppliers in several continents, requiring pilot-scale trial batches, and refusing to rely solely on low-bid quoting. Our experience points us to rejecting over-speculative ordering cycles which only bring storage costs and degradation risks.

    Turnover on the line worries every manufacturer. Chemistry skills are worth their weight in gold, and training the next shift leader takes months. We believe that strong on-the-job mentoring, combined with cross-training in every department, leads to fewer mistakes—and less lost product—than relying on batch automation or time-saving shortcuts. Our crew members use this knowledge to spot subtle texture changes in Hexetidine as they dry or granulate, nipping issues before they move downstream.

    The Value of Traceability and Long-Term Commitments

    Traceability matters, not only for regulatory compliance but for keeping peace of mind for customers who must stand behind their end products. Each drum of Hexetidine leaves our site with a full lifecycle record, from inbound material batch numbers, through in-process test results, down to shipping logbooks. Auditors inside and outside the company expect to see these records—and so do we, every time a field issue crops up months later.

    Some buyers view these steps as overcautious; we’ve learned the hard way that skipping documentation leads to expensive recall cycles or loss of key customer relationships. In over twenty years working these lines, I’ve seen more businesses fail from poor follow-through than from overengineering. Keeping data and physical samples for every lot reduces risk. The real challenge comes when scaling up from bench work to full commercial production, where every tank wash, filtration, and drying step adds up.

    Sustainability—Practical Steps That Make a Difference

    Environmental responsibility ranks high, not only in our own eyes but in those of our customers and regulatory authorities. Hexetidine waste streams, though less toxic than many heavy-metal-based biocides, still require careful neutralization and handling. In the past three years, we’ve reduced process waste by 23%, mainly by tightening reaction stoichiometry and recycling solvents. These optimizations didn’t happen overnight. They grew out of crew suggestions, running lean pilot trials, and tuning process controls gradually.

    Blunt efficiency drives every improvement. Sludgy filter cakes that clogged wastewater lines led us to introduce staged solid-liquid separations, which proved less glamorous than any high-tech fix but cut downtime and minimized emergency repairs. Changing out energy-inefficient chillers shaved power bills enough to matter, but more importantly, it smoothed the production curve in summer’s peak demand.

    We keep looking for new practices: less single-use packaging, more looped container shipping, and more attention to local sourcing for solvents and inputs. These improvements come at the suggestion of the people actually running the plant floor, rather than consultants. That’s what keeps the business both sustainable and competitive.

    Looking Ahead: Meeting New Demands With Established Experience

    Hexetidine remains a backbone for antiseptics and oral care, but we’re seeing new applications every year. Veterinary and farm hygiene, advanced wound dressings, and even anti-fouling coatings are coming onto the radar. These new markets demand proof that Hexetidine can hold up under tougher physical and chemical stressors. Every time a customer proposes a new use, we go back to the basics: what’s different about their product line, their potential incompatibilities, and their regulatory hurdles? Our job is to adapt Hexetidine production for novel formulations, testing for new variables instead of guessing.

    Working directly inside the chemical manufacturing sector means knowing real cost breakdowns: what raw materials take, what unexpected downtime really costs, and the actual labor behind every ton of product. Only with boots-on-ground perspective can we deliver a Hexetidine product that matches changing needs, supports downstream innovation, and stands up to scrutiny from buyers, regulators, and independent labs.

    The market for antiseptics keeps evolving under tightened regulations and rising end-user expectations. Those pressures challenge us to push product quality, batch integrity, and complaint response even further year by year. We respond not with slogans but stepwise upgrades—better tracking, quicker in-process monitoring, and real engagement with the feedback rolling in from our customers. Every kilo of Hexetidine reflects not just chemical know-how, but years of listening to questions, troubleshooting batch failures, and learning from every process tweak—details that make the product effective on the shelf, trusted in the clinic, and reliable worldwide.